Burning Rock Biotech Ltd (NAS:BNR)
$ 7.66 -0.12 (-1.54%) Market Cap: 78.59 Mil Enterprise Value: -5.83 Mil PE Ratio: 0 PB Ratio: 0.74 GF Score: 47/100

Q1 2022 Burning Rock Biotech Ltd Earnings Call Transcript

May 31, 2022 / 12:30PM GMT
Release Date Price: $24 (+0.84%)
Operator

Good day, ladies and gentlemen. Thank you for standing by, and welcome to Burning Rock 2022 First Quarter Earnings Conference Call.

This presentation contains forward-looking statements. These statements constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminologies such as will, expects, anticipates, future, intends, plans, believes, estimates, target, confident and similar statements.

Burning Rock may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by the officers, directors or employees to third parties.

Statements that are historical facts including statements about Burning Rock's beliefs and expectations are forward-looking statements. Such statements are based upon management's current expectations and current market and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot